Physician profile
Aswin Srinivasan
NPI 1215565528
$3,947.29
in general payments reported to CMS, 2019-2025
16 companies · $2,326 in 2025
The $2,326 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $219 · 2024: $1,402 · 2025: $2,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,709 · Education: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,708.97 |
| Education | $238.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,531.66 | 2024-2025 | Cardiomems, Dragonfly Opstar, Ensite |
| Abiomed | $404.06 | 2024-2025 | Impella |
| Heartflow, INC. | $334.41 | 2024-2025 | |
| Boston Scientific Corporation | $277.84 | 2023-2025 | Comet |
| Edwards Lifesciences Corporation | $231.30 | 2024-2025 | |
| Amgen INC. | $201.98 | 2024-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $190.35 | 2023-2025 | Uptravi, Opsumit |
| Bridgebio Pharma, INC. | $180.64 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $155.67 | 2023-2025 | Verquvo, Winrevair |
| Teleflex LLC | $130.48 | 2025 | Guideliner |
| Irhythm Technologies, INC. | $109.29 | 2024 | Zio Monitor, Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.04 | 2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $48.71 | 2024 | |
| Pfizer INC. | $29.33 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $16.80 | 2024 | Farxiga |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $15.73 | 2025 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aswin Srinivasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.